Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the publication of new findings in Cell by Sarkis K. Mazmanian, Ph.D., the […]
Whole Biome, an evidence-based microbiome company, today announced that it has secured $35 million in Series B financing. The round was led by existing investor Sequoia Capital with repeat participation from True Ventures, Khosla Ventures, […]
Emerging scientific developments have shown that microbiome-based medicinal products do not only represent a paradigm shift in human medicine, but also in veterinary medicine. With the global initiatives to curtail the indiscriminate and irresponsible use […]
A new study led by researchers from Harvard T.H. Chan School of Public Health and the Broad Institute of MIT and Harvard is the first to have observed the complex set of chemical and molecular […]
Topical application of beneficial lactobacilli and potentially other ‘live biotherapeutic products’ (LBPs) show great potential as an alternative strategy to tackle skin care problems related to disturbance of the skin microbiome, providing alternatives to the […]
Crown Laboratories, Inc. (“Crown”), a leading, fully integrated skin care company, announced it has acquired Xycrobe Therapeutics, Inc. (“Xycrobe”). Xycrobe’s technology focuses on utilizing the ubiquitous nature of skin microbes by turning them into vehicles […]
Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore Synlogic’s Synthetic Biotic™ medicine, SYNB1891, […]
MaaT Pharma announced today that the Institut National de la Propriété Industrielle (INPI), the French Patent Office, has issued three new patents to the company covering its sample collection device and the overall processes associated […]
For over 25 years, Healthy Directions has been forging a path to better health with innovative products developed by leading health experts. Today, they announce the new LifeBiome™ product line, inspired by nature and uniquely […]
BioCompute, a collaboration between The George Washington University and the FDA to improve communication of bioinformatics pipelines, today announced a new guidance for life sciences companies using next generation sequencing (NGS) analysis as part of […]
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, has raised an additional $18.5 million as an extension of its Series C […]